The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(3-Methyl-1,2,4-oxadiazol-5-yl)-N-{4-[(piperazin-1-yl)methyl]pyridin-2-yl}-1H-benzimidazol-2-amine ID: ALA4575832
PubChem CID: 129245476
Max Phase: Preclinical
Molecular Formula: C20H22N8O
Molecular Weight: 390.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1noc(-c2ccc3nc(Nc4cc(CN5CCNCC5)ccn4)[nH]c3c2)n1
Standard InChI: InChI=1S/C20H22N8O/c1-13-23-19(29-27-13)15-2-3-16-17(11-15)25-20(24-16)26-18-10-14(4-5-22-18)12-28-8-6-21-7-9-28/h2-5,10-11,21H,6-9,12H2,1H3,(H2,22,24,25,26)
Standard InChI Key: FQLDODIEEKFQOP-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
21.5097 -17.4953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5086 -18.3189 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2207 -18.7320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9345 -18.3185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9317 -17.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2189 -17.0864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7978 -17.0869 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0860 -17.4956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3358 -17.1591 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0013 -18.3081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1980 -18.4783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7898 -17.7668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9709 -17.7675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5591 -18.4790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9764 -19.1912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7939 -19.1870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6420 -17.0804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3512 -17.4864 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3517 -18.3094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0610 -18.7194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7737 -18.3075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7726 -17.4852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0588 -17.0748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5693 -19.9087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7529 -19.9981 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5868 -20.8023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3007 -21.2116 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9093 -20.6577 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8378 -21.1425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 2 0
9 12 1 0
11 10 1 0
10 8 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 1 0
17 18 1 0
18 19 1 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 24 1 0
15 24 1 0
26 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.45Molecular Weight (Monoisotopic): 390.1917AlogP: 2.47#Rotatable Bonds: 5Polar Surface Area: 107.79Molecular Species: BASEHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.14CX Basic pKa: 9.21CX LogP: 2.32CX LogD: 0.60Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.48Np Likeness Score: -1.64
References 1. Lefranc J, Schulze VK, Hillig RC, Briem H, Prinz F, Mengel A, Heinrich T, Balint J, Rengachari S, Irlbacher H, Stöckigt D, Bömer U, Bader B, Gradl SN, Nising CF, von Nussbaum F, Mumberg D, Panne D, Wengner AM.. (2020) Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor., 63 (2): [PMID:31859507 ] [10.1021/acs.jmedchem.9b01460 ]